Page 523 Acute Pain Management
P. 523




INR
 International
Normalised
Ratio

IR
 immediate‐release

IV
 intravenous

IVRA
 intravenous
regional
anaesthesia

LMWH
 low
molecular
weight
heparin

LTP
 long‐term
potentiation

M3G
 morphine‐3‐glucuronide

M6G
 morphine‐6‐glucuronide

MAM
 monoacetylmorphine

MAOI
 monoamine
oxidase
inhibitor

MC1R
 melanocortin‐1
receptor

mcg
 microgram

MEDD
 morphine
equivalent
daily
dose

mg
 milligram

mGluR
 metabotropic
glutamate
receptor

mL
 millilitre

MLAC
 minimum
local
anaesthetic
concentration

mm
 millimetre

MOBID
 Mobilization‐Observation‐Behavior‐Intensity‐Dementia
Pain
Scale

MOR
 mu‐opioid
receptor

MRI
 magnetic
resonance
imaging

MS
 methionine
synthetase

N 2O

 nitrous
oxide

NAS
 neonatal
abstinence
syndrome

NCA
 nurse‐controlled
analgesia

NCCPC‐PV
 Non‐Communicating
Children’s
Pain
Checklist
—
postoperative
version

NCCPC‐R

 Non‐Communicating
Children’s
Pain
Checklist

NDARC
 National
Drug
and
Alcohol
Research
Centre

NFCS
 Neonatal
Facial
Coding
Scale

ng
 nanogram

NHMRC
 National
Health
and
Medical
Research
Council

NIPS
 Neonatal
Infant
Pain
Scale

NK1
 neurokinin‐1

NMDA
 N‐methyl‐D‐aspartate

NNH
 number‐needed‐to‐harm

NNT
 number‐needed‐to‐treat

NO
 nitric
oxide
 ABBREVIATIONS

NRS
 numerical
rating
scale

NRTI
 nucleoside
reverse
transcriptase
inhibitor

NSAID
 non‐steroidal
anti‐inflammatory
drug



 Acute
pain
management:
scientific
evidence
 475

   518   519   520   521   522   523   524   525   526   527   528